Alkermes (ALKS)
Develops and sells neuroscience medicines spanning addiction, psychiatry and sleep disorders.
$43.29
After hours0.00 (0.00%)
At close$43.29(−2.01%)
Something off on this page? Send us feedback.
Next report
Oct 28, 26
in 36 days
EPS estimate
−$0.08
Revenue estimate
$463.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Jul '25Oct '25Feb '26May '26Jul '26Oct '26
Reported$1.04$0.13$0.52$0.49$0.34−$0.40$0.70Pending
Estimate$0.81$0.25$0.41$0.37$0.43−$0.57−$0.03−$0.08
Surprise+28.4%−48.9%+26.8%+32.9%−20.9%+29.8%+2,650.1%—
RevenueReportedEstimate
Feb '25May '25Jul '25Oct '25Feb '26May '26Jul '26Oct '26
Reported$430.0M$306.5M$390.7M$394.2M$384.5M$392.9M$496.0MPending
Estimate$379.4M$302.9M$354.5M$356.9M$378.9M$363.1M$457.4M$463.9M
Surprise+13.3%+1.2%+10.2%+10.5%+1.5%+8.2%+8.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.04 | — | — |
| Sep 2027 | $0.02 | — | — |
| Jun 2027 | $0.01 | — | — |
| Mar 2027 | −$0.14 | — | — |
| Dec 2026 | −$0.06 | — | — |
| Oct 2026 | −$0.08 | — | — |
| Jul 2026 | −$0.03 | $0.70 | +2,650.1% |
| May 2026 | −$0.57 | −$0.40 | +29.8% |
| Feb 2026 | $0.43 | $0.34 | −20.9% |
| Oct 2025 | $0.37 | $0.49 | +32.9% |
| Jul 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.04 | — | — | $473.0M | — | — | — |
| Sep 2027 | $0.02 | — | — | $478.2M | — | — | — |
| Jun 2027 | $0.01 | — | — | $484.8M | — | — | — |
| Mar 2027 | −$0.14 | — | — | $447.7M | — | — | — |
| Dec 2026 | −$0.06 | — | — | $472.8M | — | — | — |
| Oct 28, 2026 | −$0.08 | — | — | $463.9M | — | — | — |
| Jul 28, 2026 | −$0.03 | $0.70 | +2,650.1% | $457.4M | $496.0M | +8.4% | −4.2% |
| May 5, 2026 | −$0.57 | −$0.40 | +29.8% | $363.1M | $392.9M | +8.2% | +6.1% |
| Feb 25, 2026 | $0.43 | $0.34 | −20.9% | $378.9M | $384.5M | +1.5% | −7.0% |
| Oct 28, 2025 | $0.37 | $0.49 | +32.9% | $356.9M | $394.2M | +10.5% | +4.3% |
| Jul 29, 2025 | |||||||
| May 1, 2025 | |||||||
| Feb 12, 2025 | |||||||
| Oct 24, 2024 | |||||||
| Jul 24, 2024 | |||||||
| May 1, 2024 | |||||||
| Feb 15, 2024 | |||||||
| Oct 25, 2023 | |||||||
| Jul 26, 2023 | |||||||
| Apr 26, 2023 | |||||||
| Feb 16, 2023 | |||||||
| Nov 2, 2022 | |||||||
| Jul 27, 2022 | |||||||
| Apr 27, 2022 | |||||||
| Feb 16, 2022 | |||||||
| Oct 27, 2021 | |||||||
| Jul 28, 2021 | |||||||
| Apr 28, 2021 | |||||||
| Feb 11, 2021 | |||||||
| Oct 29, 2020 | |||||||
| Jul 29, 2020 | |||||||
| Apr 29, 2020 | |||||||
| Feb 13, 2020 | |||||||
| Oct 23, 2019 | |||||||
| Jul 25, 2019 | |||||||
| Apr 25, 2019 | |||||||
| Feb 14, 2019 | |||||||
| Oct 23, 2018 | |||||||
| Jul 26, 2018 | |||||||
| Apr 26, 2018 | |||||||
| Feb 14, 2018 | |||||||
| Oct 26, 2017 | |||||||
| Jul 27, 2017 | |||||||
| Apr 27, 2017 | |||||||
| Feb 15, 2017 | |||||||
| Nov 2, 2016 | |||||||
| Jul 28, 2016 | |||||||
| Apr 28, 2016 | |||||||
| Feb 25, 2016 | |||||||
| Oct 29, 2015 | |||||||
| Jul 30, 2015 |